Christina Pascucci heads out to Death Valley for an adventure to break the monotony of life amid coronavirus. She shares the natural wonders that can be found at one of the hottest places in the world, and learns about what the Oasis at Death Valley is doing to help keep people safe during their visits.

<description>
 &lt;p&gt;Christina Pascucci heads out to Death Valley for an adventure to break the monotony of life amid coronavirus. She shares the natural wonders that can be found at one of the hottest places in the world, and learns about what the Oasis at Death Valley is doing to help keep people safe during their visits. &lt;/p&gt;
 </description>

Christina Pascucci heads out to Death Valley for an adventure to break the monotony of life amid coronavirus. She shares the natural wonders that can be found at one of the hottest places in the world, and learns about what the Oasis at Death Valley is doing to help keep people safe during their visits. 

Local Adventure

XPRIZE&nbsp;is a&nbsp;non-profit organization&nbsp;that hosts&nbsp;competitions&nbsp;intended to encourage technological development to benefit humanity. The foundation is giving away a $5,000,000 prize to the team who can develop a rapid, reliable, and affordable COVID-19 test. The goal is to accelerate radical solutions to solving COVID-19 and future pandemics. Christina speaks with XPRIZE CEO Anousheh Ansari about their latest competition.

<description>
 &lt;p&gt;XPRIZE&amp;nbsp;is a&amp;nbsp;non-profit organization&amp;nbsp;that hosts&amp;nbsp;competitions&amp;nbsp;intended to encourage technological development to benefit humanity. The foundation is giving away a $5,000,000 prize to the team who can develop a rapid, reliable, and affordable COVID-19 test. The goal is to accelerate radical solutions to solving COVID-19 and future pandemics. Christina speaks with XPRIZE CEO Anousheh Ansari about their latest competition.&lt;/p&gt;
 </description>

XPRIZE is a non-profit organization that hosts competitions intended to encourage technological development to benefit humanity. The foundation is giving away a $5,000,000 prize to the team who can develop a rapid, reliable, and affordable COVID-19 test. The goal is to accelerate radical solutions to solving COVID-19 and future pandemics. Christina speaks with XPRIZE CEO Anousheh Ansari about their latest competition.

The Million Dollar Question

The race is on to develop a vaccine to fight off COVID-19. Biotech company Moderna says they're on track to finish enrollment for a Phase-3 study of its vaccine by the end of September. Dr. Anthony Fauci, the nation's top infectious disease expert, says he remains "cautiously optimistic" in regards to the vaccine. He spoke with KTLA with more information about its development, when it can be expected, who will receive it, and more.

<description>
 &lt;p&gt;The race is on to develop a vaccine to fight off COVID-19. Biotech company Moderna says they're on track to finish enrollment for a Phase-3 study of its vaccine by the end of September. Dr. Anthony Fauci, the nation's top infectious disease expert, says he remains "cautiously optimistic" in regards to the vaccine. He spoke with KTLA with more information about its development, when it can be expected, who will receive it, and more.&lt;/p&gt;
 </description>

The race is on to develop a vaccine to fight off COVID-19. Biotech company Moderna says they're on track to finish enrollment for a Phase-3 study of its vaccine by the end of September. Dr. Anthony Fauci, the nation's top infectious disease expert, says he remains "cautiously optimistic" in regards to the vaccine. He spoke with KTLA with more information about its development, when it can be expected, who will receive it, and more.

A Promising Vaccine with Dr. Anthony Fauci

Since the begining of the pandemic, doctors and scientists around the world have been hard at work trying to develop vaccines and treatments for COVID-19. Cardiologist Dr. Norman Lepor is involved in the COLCORONA study, a government-funded clinical trial to get the answer as to the effectiveness of the drug called colchicine, which doctors hope may help patients diagnosed with COVID-19 avoid complications like hospitalizations, the need for ventilator assisted breathing, or even death. Christina Pascucci speaks with Dr. Lepor to learn more about the COLCORONA Study.

<description>
 &lt;p&gt;Since the begining of the pandemic, doctors and scientists around the world have been hard at work trying to develop vaccines and treatments for COVID-19. Cardiologist Dr. Norman Lepor is involved in the COLCORONA study, a government-funded clinical trial to get the answer as to the effectiveness of the drug called colchicine, which doctors hope may help patients diagnosed with COVID-19 avoid complications like hospitalizations, the need for ventilator assisted breathing, or even death. Christina Pascucci speaks with Dr. Lepor to learn more about the COLCORONA Study.&lt;/p&gt;
 </description>

Since the begining of the pandemic, doctors and scientists around the world have been hard at work trying to develop vaccines and treatments for COVID-19. Cardiologist Dr. Norman Lepor is involved in the COLCORONA study, a government-funded clinical trial to get the answer as to the effectiveness of the drug called colchicine, which doctors hope may help patients diagnosed with COVID-19 avoid complications like hospitalizations, the need for ventilator assisted breathing, or even death. Christina Pascucci speaks with Dr. Lepor to learn more about the COLCORONA Study.

The COLCORONA Study

On March 5th, 2020 Gregg Garfield checked himself into St. Josephs Providence Hospital in Burbank after a ski trip in Northern Italy. He would come to be known as "Patient Zero," the hospital's first COVID-19 patient. While in the hospital, Gregg's health went into a rapid decline, and his chances of survival appeared to be slim to none. In the end, however, even after seemingly knocking on death’s door, Gregg would be a survivor. He shares his story with Christina Pascucci.&nbsp;&nbsp;&nbsp;

<description>
 &lt;p&gt;On March 5th, 2020 Gregg Garfield checked himself into St. Josephs Providence Hospital in Burbank after a ski trip in Northern Italy. He would come to be known as "Patient Zero," the hospital's first COVID-19 patient. While in the hospital, Gregg's health went into a rapid decline, and his chances of survival appeared to be slim to none. In the end, however, even after seemingly knocking on death’s door, Gregg would be a survivor. He shares his story with Christina Pascucci.&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/p&gt;
 </description>

On March 5th, 2020 Gregg Garfield checked himself into St. Josephs Providence Hospital in Burbank after a ski trip in Northern Italy. He would come to be known as "Patient Zero," the hospital's first COVID-19 patient. While in the hospital, Gregg's health went into a rapid decline, and his chances of survival appeared to be slim to none. In the end, however, even after seemingly knocking on death’s door, Gregg would be a survivor. He shares his story with Christina Pascucci.   

Beating the Odds

From KTLA 5 News in Los Angeles, Coronavirus Daily is your go-to source for the latest news regarding the COVID-19 pandemic. Producer Bobby Gonzalez and reporter Christina Pascucci break down the day's headlines, talk with doctors and medical experts, and give you the information you need to know to stay informed and healthy.

Coronavirus Weekly

Details

Recent Episodes